| Announce Date | 08/27/2025 | 
| EPS Normalized Actual | $0.75 (Beat by $0.005) | 
| EPS GAAP Actual | $0.75 (Beat by $0.005) | 
| Revenue Actual | $13.932B | 
| Revenue Surprise | Beat by $13932M | 
| Announce Date | 10/30/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.97169 | 
| EPS GAAP Estimate | $0.97169 | 
| Revenue Estimate | $14.566107226B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Oct 2029 | 3.5194 | 7.87 | 3.49105 | 3.55155 | 2 | 
| Oct 2028 | 3.48 | 7.96 | 3.45197 | 3.51179 | 3 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.81 | -0.10055 | 13.932B | 2.96% | 146.05M | 
| FQ2 2025 (Apr 2025) | 0.43 | 0.43 | 13.22B | 3.47% | 13220M | 
| FQ1 2025 (Jan 2025) | 0.6 | 0.6 | 13.504B | 2.36% | 13504M | 
| FQ4 2024 (Oct 2024) | 0.94 | 0.94 | 14.055B | 1.69% | 14055M | 
| FQ3 2024 (Jul 2024) | 0.65 | 0.65 | 13.519B | 2.39% | 13519M | 
| FQ2 2024 (Apr 2024) | 0.62 | 0.62 | 12.761B | -1.19% | 12761M | 
| FQ1 2024 (Jan 2024) | 0.62 | 0.62 | 13.185B | -4.88% | 13185M | 
| FQ4 2023 (Oct 2023) | 0.98 | 0.98 | 13.817B | -7.12% | 13817M | 
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
0.97169
Consensus Revenue Estimates
14.566107226B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 1.09304 | -- | 1.0796 | 1.10818 | 9 | 
| FQ3 2027 (Jul 2027) | 0.99016 | -- | 0.97799 | 1.00388 | 6 | 
| FQ2 2027 (Apr 2027) | 0.98821 | -- | 0.97857 | 0.9959 | 4 | 
| FQ1 2027 (Jan 2027) | 0.84251 | -- | 0.81443 | 0.85644 | 9 | 
| FQ4 2026 (Oct 2026) | 1.0082 | -- | 0.98734 | 1.03277 | 5 | 
| FQ3 2026 (Jul 2026) | 0.9102 | 11.01 | 0.89137 | 0.93238 | 2 | 
| FQ2 2026 (Apr 2026) | 0.94052 | 54.28 | 0.92106 | 0.96344 | 2 | 
| FQ1 2026 (Jan 2026) | 0.88931 | 32.53 | 0.86879 | 0.91409 | 2 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 15.3B | -- | 15.16B | 15.46B | 6 | 
| FQ3 2027 (Jul 2027) | 14.53B | -- | 14.39B | 14.68B | 4 | 
| FQ2 2027 (Apr 2027) | 13.29B | -- | 13.19B | 13.37B | 2 | 
| FQ1 2027 (Jan 2027) | 14.28B | -- | 13.91B | 14.46B | 5 | 
| FQ4 2026 (Oct 2026) | 14.65B | -- | 14.42B | 14.93B | 3 | 
| FQ3 2026 (Jul 2026) | 13.76B | -1.27 | 13.54B | 14.01B | 3 | 
| FQ2 2026 (Apr 2026) | 13.26B | 0.28 | 13.05B | 13.51B | 3 | 
| FQ1 2026 (Jan 2026) | 14.1B | 4.24 | 13.85B | 14.4B | 3 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.91055 | 0.81 | -0.10055 | -12.41% | 
| FQ2 2025 (Apr 2025) | 0.43 | 0.43 | 100% | |
| FQ1 2025 (Jan 2025) | 0.6 | 0.6 | 100% | |
| FQ4 2024 (Oct 2024) | 0.94 | 0.94 | 100% | |
| FQ3 2024 (Jul 2024) | 0.65 | 0.65 | 100% | |
| FQ2 2024 (Apr 2024) | 0.62 | 0.62 | 100% | |
| FQ1 2024 (Jan 2024) | 0.62 | 0.62 | 100% | |
| FQ4 2023 (Oct 2023) | 0.98 | 0.98 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $13.79B | $13.93B | $146.05M | 1.05% | 
| FQ2 2025 (Apr 2025) | $0B | $13.22B | $13220M | 100% | 
| FQ1 2025 (Jan 2025) | $0B | $13.5B | $13504M | 100% | 
| FQ4 2024 (Oct 2024) | $0B | $14.06B | $14055M | 100% | 
| FQ3 2024 (Jul 2024) | $0B | $13.52B | $13519M | 100% | 
| FQ2 2024 (Apr 2024) | $0B | $12.76B | $12761M | 100% | 
| FQ1 2024 (Jan 2024) | $0B | $13.19B | $13185M | 100% | 
| FQ4 2023 (Oct 2023) | $0B | $13.82B | $13817M | 100% |